211 related articles for article (PubMed ID: 33712333)
1. Serum copeptin and NT-proBNP is associated with central aortic stiffness and flow hemodynamics in adolescents with type 1 diabetes: A pilot study.
Melena I; Bjornstad P; Schäfer M; Hunter KS; Barker AJ; Baumgartner A; Chung L; Wiromrat P; Truong U; Reusch JEB; Nadeau KJ
J Diabetes Complications; 2021 May; 35(5):107883. PubMed ID: 33712333
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study.
Wannamethee SG; Welsh P; Whincup PH; Lennon L; Papacosta O; Sattar N
Eur J Heart Fail; 2014 Jan; 16(1):25-32. PubMed ID: 23901058
[TBL] [Abstract][Full Text] [Related]
3. Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP? (ZODIAC-46).
Riphagen IJ; Logtenberg SJ; Groenier KH; van Hateren KJ; Landman GW; Struck J; Navis G; Kootstra-Ros JE; Kema IP; Bilo HJ; Kleefstra N; Bakker SJ
Atherosclerosis; 2015 Sep; 242(1):179-85. PubMed ID: 26201002
[TBL] [Abstract][Full Text] [Related]
4. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke.
Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B
Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274
[TBL] [Abstract][Full Text] [Related]
5. Elevated copeptin, arterial stiffness, and elevated albumin excretion in adolescents with type 1 diabetes.
Wiromrat P; Bjornstad P; Vinovskis C; Chung LT; Roncal C; Pyle L; Lanaspa MA; Johnson RJ; Cherney DZ; Reznick-Lipina TK; Bishop F; Maahs DM; Wadwa RP
Pediatr Diabetes; 2019 Dec; 20(8):1110-1117. PubMed ID: 31433534
[TBL] [Abstract][Full Text] [Related]
6. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
[TBL] [Abstract][Full Text] [Related]
7. Relationship of N-Terminal fragment of Pro-B-Type Natriuretic Peptide and copeptin with erythrocytes-related parameters: A population-based study.
Ruperti Repilado FJ; Aeschbacher S; Bossard M; Schoen T; Gugganig R; van der Stouwe JG; Krisai P; Kofler T; Buser A; Risch M; Risch L; Mueller C; Conen D
Clin Biochem; 2016 Jun; 49(9):651-656. PubMed ID: 26851156
[TBL] [Abstract][Full Text] [Related]
8. N-Terminal Prohormone of Brain Natriuretic Peptide but not C-Terminal Pre-Pro Vasopressin (Copeptin) Level is Associated with the Response to Antihypertensive Therapy in Haemodialysis Patients.
Wyskida K; Ficek J; Ficek R; Adamska D; Jędrzejowska P; Wajda J; Klein D; Witkowicz J; Rotkegel S; Spiechowicz-Zatoń U; Kocemba-Dyczek J; Ciepał J; Więcek A; Olszanecka-Glinianowicz M; Chudek J
Kidney Blood Press Res; 2017; 42(6):1013-1022. PubMed ID: 29190613
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of hemodynamic stress and aortic stiffness after STEMI: a cross-sectional analysis.
Reinstadler SJ; Feistritzer HJ; Klug G; Mayr A; Huybrechts L; Hammerer-Lercher A; Mair J; Franz WM; Metzler B
Dis Markers; 2015; 2015():717032. PubMed ID: 25960598
[TBL] [Abstract][Full Text] [Related]
10. Correlations of arterial stiffness/central hemodynamics with serum cardiac troponin T and natriuretic peptide levels in a middle-aged male worksite cohort.
Kimura K; Tomiyama H; Matsumoto C; Odaira M; Shiina K; Nagata M; Yamashina A
J Cardiol; 2015 Aug; 66(2):135-42. PubMed ID: 25467920
[TBL] [Abstract][Full Text] [Related]
11. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
Costacou T; Saenger AK; Orchard TJ
Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
[TBL] [Abstract][Full Text] [Related]
12. A multivariable miRNA signature delineates the systemic hemodynamic impact of arteriovenous shunt placement in a pilot study.
Henn D; Abu-Halima M; Kahraman M; Falkner F; Fischer KS; Barrera JA; Chen K; Gurtner GC; Keller A; Kneser U; Meese E; Schmidt VJ
Sci Rep; 2020 Dec; 10(1):21809. PubMed ID: 33311598
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.
Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R
Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836
[TBL] [Abstract][Full Text] [Related]
14. Changes in Arterial Stiffness and N-terminal pro-brain natriuretic peptide Levels after Endovascular Repair of Descending Thoracic Aorta.
Moulakakis KG; Kadoglou NPE; Antonopoulos CN; Mylonas SN; Kakisis J; Papadakis I; Karakitsos P; Liapis CD
Ann Vasc Surg; 2017 Jan; 38():220-226. PubMed ID: 27522979
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke.
Tu WJ; Dong X; Zhao SJ; Yang DG; Chen H
J Neuroendocrinol; 2013 Sep; 25(9):771-8. PubMed ID: 23701638
[TBL] [Abstract][Full Text] [Related]
16. Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy.
Sahin I; Gungor B; Ozkaynak B; Uzun F; Küçük SH; Avci II; Ozal E; Ayça B; Cetın S; Okuyan E; Dinckal MH
Clin Cardiol; 2017 Jan; 40(1):32-37. PubMed ID: 27768229
[TBL] [Abstract][Full Text] [Related]
17. Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.
Düngen HD; Tscholl V; Obradovic D; Radenovic S; Matic D; Musial Bright L; Tahirovic E; Marx A; Inkrot S; Hashemi D; Veskovic J; Apostolovic S; von Haehling S; Doehner W; Cvetinovic N; Lainscak M; Pieske B; Edelmann F; Trippel T; Loncar G
ESC Heart Fail; 2018 Apr; 5(2):288-296. PubMed ID: 29476612
[TBL] [Abstract][Full Text] [Related]
18. Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study.
Wannamethee SG; Welsh P; Lennon L; Papacosta O; Whincup PH; Sattar N
Diabetologia; 2016 Sep; 59(9):1904-12. PubMed ID: 27312697
[TBL] [Abstract][Full Text] [Related]
19. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study.
Narayan H; Dhillon OS; Quinn PA; Struck J; Squire IB; Davies JE; Ng LL
Clin Sci (Lond); 2011 Jul; 121(2):79-89. PubMed ID: 21309746
[TBL] [Abstract][Full Text] [Related]
20. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
